Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model? (Q38021197)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 June 2012
edit
Language Label Description Also known as
English
Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?
scientific article published on 15 June 2012

    Statements

    Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit